Exelixis reported $329.12M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Akebia Therapeutics AKBA:US USD 98.04M 5.19M
Amgen AMGN:US USD 3.91B 504M
AstraZeneca AZN:LN USD 9.74B 495M
Bayer BAYN:GR EUR 10.08B 2.57B
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Cytokinetics CYTK:US USD 133.2M 33.36M
Eisai 4523:JP JPY 176.54B 283M
Eli Lilly And LLY:US USD 5.27B 12.8M
Esperion Therapeutics ESPR:US USD 60.6M 10.61M
Exelixis EXEL:US USD 329.12M 6.6M
Genmab GEN:DC DKK 2.16B 241M
Glaxosmithkline GSK:US GBP 6.64B 790M
Immunogen IMGN:US USD 92.8M 17.59M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Macrogenics MGNX:US USD 66.69M 1.13M
Merk MRK:US USD 10.97B 1.31B
Mirati Therapeutics MRTX:US USD 191.87M 9.31M
Moderna Inc MRNA:US USD 2.2B 104M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Novartis NOVN:VX USD 10.67B 183M
Pfizer PFE:US USD 13.23B 2.41B
Puma Biotechnology PBYI:US USD 54.71M 7.19M
Seattle Genetics SGEN:US USD 703.1M 72.49M
Takeda 4502:JP JPY 897.87B 75.92B
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
Xencor XNCR:US USD 65.65M 7.47M
YTE INCY:US USD 684.93M 27.96M